1. Healthcare, Regulatory and Reimbursement Landscape -
Morocco
Report Details:
Published:November 2012
No. of Pages: 146
Price: Single User License – US$1995
Healthcare, Regulatory and Reimbursement Landscape - Morocco
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory
and Reimbursement Landscape - Morocco”. An essential source of information and analysis on
the Moroccan healthcare, regulatory and reimbursement landscape, this report identifies the key
trends in the Morocco healthcare market, as well as providing insights on the demographic,
regulatory, and reimbursement landscape, and the healthcare infrastructure of Morocco. Most
importantly, the report provides valuable insights on the trends and segmentation of the
pharmaceutical market.
This report is built using data and information sourced from proprietary databases, secondary
research and in-house analysis by GlobalData’s team of industry experts.
In 2011, Morocco’s population was 32.2 million, largely due to a positive balance between the birth
rate and mortality rate. The mortality rate is almost steady due to increase in number of births
attended by skilled healthcare personnel. The pharmaceutical market was estimated at $1.16
billion in 2011 and is expected to reach $2.96 billion by 2020 at a projected CAGR of 11%.
The positive trends in Morocco healthcare market can be attributed primarily to -
- Expanding prevalence of chronic diseases
- Healthcare initiatives taken by the government of Morocco to improve the healthcare insurance
coverage for the Moroccan population
Scope
The report provides information on the Morocco healthcare, regulatory and reimbursement
landscape of Morocco. Its scope includes -

2. - Overview of the pharmaceutical and medical devices market, including size, segmentation, and
key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market. The key players
covered for the pharmaceutical market are Sanofi, GlaxoSmithKline, Pfizer, SOTHEMA and
Laprophan.
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare
reimbursement process, regulatory agencies and market authorization processes for new drug
and medical devices.
- Detailed analysis of Morocco’s political and economic environment, including the economic
indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.
Reasons to buy
The report will enhance your decision-making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare
market.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical market segments and companies likely to impact the healthcare market in the
future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present the most opportunities for consolidation, investment and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
Get your copy of this report @
http://www.reportsnreports.com/reports/209356-healthcare-regulatory-and-reimbursement-landscape-
morocco.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Report Guidance 10
3 Overview of the Pharmaceutical and Medical Devices Market 11
3.1 Pharmaceutical Market 11
3.1.1 Market Overview 11
3.1.2 Supply Channels 14
3.1.3 Market Segments 16
3.1.4 Major Disease Areas 18

3. 3.1.5 Major Players 19
3.2 Medical Device Market 44
3.2.1 Market Overview 44
3.3 Market Drivers and Barriers 45
3.3.1 Drivers 45
3.3.2 Barriers 46
4 Market Access 48
4.1 Reimbursement and Payer Landscape 48
4.1.1 Healthcare System Overview 48
4.1.2 Reimbursement Process 48
4.1.3 Overview of Insurance Providers 49
4.1.4 Patient Share in Healthcare Spending 52
4.1.5 Price Trend in Healthcare Services 53
4.1.6 Pricing Policies 54
4.2 Regulatory Landscape 56
4.2.1 Overview of Regulatory Agencies 56
4.2.2 Drug Approval Process 57
4.2.3 New Device Approval Process 59
4.2.4 Licensing Process for Pharmaceutical Establishments 59
4.2.5 Licensing Process for Exports and Imports 60
4.2.6 Intellectual Property Rights Landscape 61
4.2.7 Clinical Trial Regulations 65
4.2.8 Pharmaceutical Advertising Regulations 67
4.2.9 Pharmacy Regulations 69
4.2.10 Labeling and Packing Regulations 70
5 Country Analysis 71
5.1 Political Environment 71
5.1.1 Political Structure 71
5.1.2 Analysis of the Current Political Environment 72
5.1.3 Healthcare Policy Initiatives 73
5.2 Economic Landscape 76
5.3 Economic Indicators 78
5.3.1 Gross Domestic Product 78
5.3.2 Gross National Income 82
5.3.3 Inflation 83
5.3.4 Currency Exchange Rate 87
5.3.5 Foreign Direct Investment 88
5.3.6 Foreign Exchange Reserves 89
5.3.7 Trade Balance 90
5.3.8 Government Structural Balance 92
5.3.9 Total Central Government Debt 94
5.3.10 Public External Debt 95

4. 5.3.11 Major Industries 96
5.4 Demographics 97
5.4.1 Population 97
5.4.2 Education and Literacy 112
5.4.3 Employment 114
5.4.4 Disease Burden 115
5.5 Healthcare Infrastructure 116
5.5.1 Healthcare Facilities 116
5.5.2 Healthcare Parameters 121
5.5.3 Environmental Health 123
5.5.4 Healthcare Personnel 127
5.6 Healthcare Expenditure 129
5.6.1 Overview 129
5.6.2 Major Components of Healthcare Spending 130
5.6.3 Share of Public and Private Sector 131
5.7 Trade Associations 132
5.7.1 Moroccan Pharmaceutical Industry Association 132
5.7.2 Morocco Health Innovation 132
5.8 Trade Fairs 133
6 Opportunities and Challenges 134
6.1 Opportunities 134
6.2 Challenges 135
7 Appendix 137
7.1 Abbreviations 137
7.2 Bibliography 139
7.3 Methodology 144
7.3.1 Coverage 144
7.3.2 Secondary Research 144
7.3.3 Forecasting 145
7.3.4 Primary Research 145
7.3.5 Expert Panel Validation 145
7.4 Contact Us 145
7.5 Disclaimer 146
1.1 List of Tables
Table 1: Pharmaceutical Market ($m), Morocco, 2006 - 2011 12
Table 2: Pharmaceutical Market ($m), Morocco, Forecast, 2012 - 2020* 13
Table 3: Generic Pharmaceutical Market, Revenue ($m), Morocco, 2006 - 2011 16
Table 4: Generic Pharmaceutical Market, Revenue ($m), Morocco, Forecast, 2012 - 2020 17
Table 5: Major Products, Sanofi, Global, Revenue ($m), 2012 20
Table 6: Major Products, Sanofi-aventis Morocco, 2012 20
Table 7: Major Products, Maphar, 2012 21

5. Table 8: Late Stage Pipeline, Sanofi, 2012 21
Table 9: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2012 25
Table 10: Late Stage Pipeline, GlaxoSmithKline, 2012 25
Table 11: Major Products, Pfizer, Global, Revenue ($m), 2012 31
Table 12: Late Stage Pipeline, Pfizer, 2012 32
Table 13: Major Products, Sothema, 2012 37
Table 14: Major Products, Laprophan, 2012 41
Table 15: Healthcare Spending, Morocco, Patient’s Share (%), 2005 - 2010 52
Table 16: Annual Price Change, Morocco, Healthcare Segments (%), 2007 - 2011 54
Table 17: GDP Per Capita ($), Morocco, 2006 - 2011 78
Table 18: GDP Per Capita ($), Morocco, Forecast, 2012 - 2020 79
Table 19: GDP, Morocco, Annual Growth (%), 2006 - 2011 80
Table 20: GDP, Morocco, Annual Growth (%), Forecast, 2012 - 2020 81
Table 21: GNI Per Capita ($), Morocco, 2006 - 2011 82
Table 22: Average Consumer Price Index, Morocco, 2006 - 2011 83
Table 23: Average Consumer Price Index, Morocco, Forecast, 2012 - 2020 84
Table 24: Average Consumer Price, Morocco, Annual Change (%), 2006 - 2011 85
Table 25: Average Consumer Price, Morocco, Annual Change (%), 2012 - 2020 86
Table 26: Currency Exchange Rate (MAD/$), Morocco, 2006 - 2011 87
Table 27: Foreign Direct Investment ($bn), Morocco, 2006 - 2011 88
Table 28: Foreign Exchange Reserves ($bn), Morocco, 2006 - 2011 89
Table 29: Exports of Goods and Services ($bn), Morocco, 2006 - 2011 90
Table 30: Imports of Goods and Services ($bn), Morocco, 2006 - 2011 91
Table 31: General Government Structural Balance ($bn), Morocco, 2006 - 2011 92
Table 32: General Government Structural Balance ($bn), Morocco, Forecast, 2012 - 2020 93
Table 33: Total Central Government Debt ($bn), Morocco, 2006 - 2011 94
Table 34: Public External Debt ($bn), Morocco, 2006 - 2011 95
Table 35: Major Industries, Morocco, Production ($bn), 2009 96
Table 36: Population (million), Morocco, 2006 - 2011 97
Table 37: Population (million), Morocco, Forecast, 2012 - 2020 98
Table 38: Urban and Rural Population, Morocco, Share (%), 2006 - 2011 99
Table 39: Urban and Rural Population, Morocco, Share (%), Forecast, 2012 - 2020 100
Table 40: Age Groups, Population Distribution (%), Morocco, 2006 - 2011 101
Table 41: Age Groups, Population Distribution (%), Morocco, Forecast, 2012 - 2020 102
Table 42: Births (Per 1,000 Population), Morocco, 2005 - 2010 103
Table 43: Mortality (Per 1,000 Population), Morocco, 2005 - 2010 104
Table 44: Major Causes of Mortality (‘000s), Morocco, 2008 105
Table 45: Children Table 46: Immunization (‘000s), Morocco, 2005-2010 107
Table 47: Major Causes of Male Mortality (‘000s), Morocco, 2008 108
Table 48: Major Causes of Female Mortality (‘000s), Morocco, 2008 109
Table 49: Gender Ratio (M/F), Morocco, 2006 - 2011 110
Table 50: Life Expectancy at Birth (Years), Morocco, 2006 - 2011 111

6. Table 51: Levels of Education, Morocco, Gross Enrolment (%), 2010 113
Table 52: Unemployment Rate (%), Morocco, 2006 - 2011 114
Table 53: Major Diseases, Morocco, DALY (Per 100,000 Population), 2004 115
Table 54: Number of Hospitals, Morocco, 2006 - 2011 116
Table 55: Public and Private Hospitals, Morocco, 2006 - 2011 117
Table 56: Basic Public Urban - Rural Health Centers, Morocco, 2006 - 2011 118
Table 57: Dialysis Units in Hospitals (Per 100,000 Population), Morocco, 2006 - 2011 119
Table 58: Diagnostic Services, Morocco, 2011 120
Table 59: Hospital Beds (Per 100,000 Population), Morocco, 2006 - 2011 121
Table 60: Physicians (Per 100,000 Population), Morocco, 2006 - 2011 122
Table 61: CO2 Emissions (Million Tons), Morocco, 2005 - 2010 123
Table 62: PM10 (Micrograms Per Cubic Meter), Morocco, 2005 - 2010 124
Table 63: Organic Water Pollutant Emissions (Metric Tons per Day), Morocco, 2005-2010 125
Table 64: Disposable Solid Waste, Share (%), Morocco, 2011 126
Table 65: Nurses (Per 100,000 Population), Morocco, 2006 - 2011 128
Table 66: Dentists (Per 100,000 Population), Morocco, 2006 - 2011 128
Table 67: Healthcare Expenditure (% of GDP), Morocco, 2006 - 2011 129
Table 68: Public Healthcare Expenditure, Morocco, Share of Major Components (%), 2011 130
Table 69: Healthcare Expenditure, Morocco, Public-Private Share (%), 2006- 2011* 131
Table 70: Major Healthcare Trade Fairs, Morocco, 2012 133
1.2 List of Figures
Figure 1: Pharmaceutical Market ($m), Morocco, 2006 - 2011 12
Figure 2: Pharmaceutical Market ($m), Morocco, Forecast, 2012 - 2020* 13
Figure 3: Distribution Channels, Morocco, Price Margins (%), 2007 15
Figure 4: Generic Pharmaceutical Market, Revenue ($m), Morocco, 2006 - 2011 16
Figure 5: Generic Pharmaceutical Market, Revenue ($m), Morocco, Forecast, 2012 - 2020 17
Figure 6: Drivers and Barriers, Healthcare Market, Morocco, 2012 47
Figure 7: Structure of the Healthcare Insurance System, Morocco, 2011 49
Figure 8: Healthcare Spending, Morocco, Patient’s Share (%), 2005 - 2010 52
Figure 9: Annual Price Change, Morocco, Healthcare Segments (%), 2007 - 2011 53
Figure 10: Pricing Procedure, Morocco, 2012 55
Figure 11: New Drug Approval Process, Morocco, 2012 58
Figure 12: Patent Approval Process, Morocco, 2012 62
Figure 13: Trademark Approval Process, Morocco, 2012 64
Figure 14: Clinical Trial Approval Process, Morocco, 2012 66
Figure 15: Advertisement Approval Process, Morocco, 2012 68
Figure 16: GDP Per Capita ($), Morocco, 2006 - 2011 78
Figure 17: GDP Per Capita ($), Morocco, Forecast, 2012 - 2020 79
Figure 18: GDP, Morocco, Annual Growth (%), 2006 - 2011 80
Figure 19: GDP, Morocco, Annual Growth (%), Forecast, 2012 - 2020 81
Figure 20: GNI Per Capita ($), Morocco, 2006 - 2011 82

7. Figure 21: Average Consumer Price Index, Morocco, 2006 - 2011 83
Figure 22: Average Consumer Price Index, Morocco, Forecast, 2012 - 2020 84
Figure 23: Average Consumer Price, Morocco, Annual Change (%), 2006 - 2011 85
Figure 24: Average Consumer Price, Morocco, Annual Change (%), 2012 - 2020 86
Figure 25: Currency Exchange Rate (MAD/$), Morocco, 2006 - 2011 87
Figure 26: Foreign Direct Investment ($bn), Morocco, 2006 - 2011 88
Figure 27: Foreign Exchange Reserves ($bn), Morocco, 2006 - 2011 89
Figure 28: Exports of Goods and Services ($bn), Morocco, 2006 - 2011 90
Figure 29: Imports of Goods and Services ($bn), Morocco, 2006 - 2011 91
Figure 30: General Government Structural Balance ($bn), Morocco, 2006 - 2011 92
Figure 31: General Government Structural Balance ($bn), Morocco, Forecast, 2012 - 2020 93
Figure 32: Total Central Government Debt ($bn), Morocco, 2006 - 2011 94
Figure 33: Public External Debt ($bn), Morocco, 2006 - 2011 95
Figure 34: Major Industries, Morocco, Production ($bn), 2009 96
Figure 35: Population (million), Morocco, 2006 - 2011 97
Figure 36: Population (million), Morocco, Forecast, 2012 - 2020 98
Figure 37: Urban and Rural Population, Morocco, Share (%), 2006 - 2011 99
Figure 38: Urban and Rural Population, Morocco, Share (%), Forecast, 2012 - 2020 100
Figure 39: Age Groups, Population Distribution (%), Morocco, 2006 - 2011 101
Figure 40: Age Groups, Population Distribution (%), Morocco, Forecast, 2012 - 2020 102
Figure 41: Births (Per 1,000 Population), Morocco, 2005 - 2010 103
Figure 42: Mortality (Per 1,000 Population), Morocco, 2005 - 2010 104
Figure 43: Major Causes of Mortality (‘000s), Morocco, 2008 105
Figure 44: Children Figure 45: Immunization (‘000s), Morocco, 2005-2010 107
Figure 46: Major Causes of Male Mortality (‘000s), Morocco, 2008 108
Figure 47: Major Causes of Female Mortality (‘000s), Morocco, 2008 109
Figure 48: Gender Ratio (M/F), Morocco, 2006 - 2011 110
Figure 49: Life Expectancy at Birth (Years), Morocco, 2006 - 2011 111
Figure 50: Levels of Education, Morocco, Gross Enrolment (%), 2010 113
Figure 51: Unemployment Rate (%), Morocco, 2006 - 2011 114
Figure 52: Major Diseases, Morocco, DALY (Per 100,000 Population), 2004 115
Figure 53: Number of Hospitals, Morocco, 2006 - 2011 116
Figure 54: Public and Private Hospitals, Morocco, 2006 - 2011 117
Figure 55: Basic Public Urban - Rural Health Centers, Morocco, 2006 - 2011 118
Figure 56: Dialysis Units in Hospitals (Per 100,000 Population), Morocco, 2006 - 2011 119
Figure 57: Diagnostic Services, Morocco, 2011 120
Figure 58: Hospital Beds (Per 100,000 Population), Morocco, 2006 - 2011 121
Figure 59: Physicians (Per 100,000 Population), Morocco, 2006 - 2011 122
Figure 60: CO2 Emissions (Million Tons), Morocco, 2005 - 2010 123
Figure 61: PM10 (Micrograms Per Cubic Meter), Morocco, 2005 - 2010 124
Figure 62: Organic Water Pollutant Emissions (Metric Tons per Day), Morocco, 2005 - 2010 125
Figure 63: Disposable Solid Waste, Share (%), Morocco, 2011 126

8. Figure 64: Nurses (Per 100,000 Population), Morocco, 2006 - 2011 127
Figure 65: Dentists (Per 100,000 Population), Morocco, 2006 - 2011 128
Figure 66: Healthcare Expenditure (% of GDP), Morocco, 2006 - 2011 129
Figure 67: Public Healthcare Expenditure, Morocco, Share of Major Components (%), 2011 130
Figure 68: Healthcare Expenditure, Morocco, Public-Private Share (%), 2006 – 2011* 131
Figure 69: Opportunities and Challenges, Healthcare Market, Morocco, 2012 136
Contact: sales@reportsandreports.com for more information.